Doesn't work that way in this business. Contrary t

Doesn't work that way in this business. Contrary to what some might think, Koos doesn't sit at his desk, wondering what the shareholders are thinking (not at this point, anyway). The scientists behind the medicines/treatments darn sure don't.

There is a long list of people eager to participate in trials for treatment of AA. People desperate to find a cure to their nasty disease. Now, they (BMSN, et al) do know that. The news would be posted within hours to get the ball rolling for trials. Especially when you consider the limited number of patients that will participate. The dynamics are mind boggling to those not familiar with how it all works. Sometimes so to those of us actually familiar with it. If approval were already a reality, certain entities would have been advised asap (perhaps within hours), databases updated, etc., etc., etc.,  This is not the case as of yet.

HOWEVER, that is not to say that there has not been a response and the final details are being worked out. I have learned that there is some talk within certain oncology groups that have a keen interest in Hema. Whether or not this talk is a result of internet chatter or intimate discussions between scientists & doctors, I cannot say.

It does look as though some whales have decided to come for a look-see though.

I increased my position close to EOD.